Strand Life Sciences
Strand Life Sciences Launches ‘STRAND LB’ – A Ground-Breaking Method For Monitoring Cancer
Cancer-causing BRCA Gene Mutations at Least Three Times More Prevalent in India Compared to Western Countries Reveals Study
Extension of CAP accreditation following a recent inspection of Strand Centre for Genomics and Personalized Medicine Lab in Bangalore November 21, 2017 |…
read moreOctober 28, 2017 | New Delhi, India Strand Life Sciences, one of India’s foremost bioinformatics and genomic profiling firms, has launched the “Spread Pink.…
read moreScientists from Strand Life Sciences will demonstrate ‘Strand NGS’, an all-in-one next generation sequencing software at the 67th Annual Meeting of the American Society…
read moreStrand Life Sciences today released the findings of their study on Hereditary Breast and Ovarian Cancer Cases in India – Study highlights that BRCA…
read moreStrand LB helps monitor lung, breast, colorectal and other cancers for tumor presence, response, and recurrence April 11, 2017 | Bangalore, India According to…
read moreStrand NGS 3.0 release with processing improvements promise 2x speedup compared to the global benchmark March 31, 2017 | Bangalore, India Strand Life Sciences…
read more